Chemmart Indapamide

Country: Аустралија

Језик: Енглески

Извор: Department of Health (Therapeutic Goods Administration)

Купи Сада

Активни састојак:

Indapamide hemihydrate

Доступно од:

Apotex Pty Ltd

Класа:

Medicine Registered

Информативни летак

                                CHEMMART INDAPAMIDE
 
_Contains the active ingredient, indapamide hemihydrate (pronounced
ind-ap-a-mide)_
CONSUMER MEDICINE INFORMATION
   
 
 
WHAT IS IN THIS LEAFLET
READ THIS LEAFLET CAREFULLY BEFORE
TAKING YOUR MEDICINE.
This leaflet answers some common
questions about indapamide. It does
not contain all the available
information. It does not take the
place of talking to your doctor or
pharmacist.
The information in this leaflet was
last updated on the date listed on the
last page. More recent information on
this medicine may be available.
ASK YOUR DOCTOR OR PHARMACIST:
•
if there is anything you do not
understand in this leaflet,
•
if you are worried about taking
your medicine, or
•
to obtain the most up-to-date
information
All medicines have risks and
benefits. Your doctor has weighed
the risks of you using this medicine
against the benefits they expect it
will have for you.
Pharmaceutical companies cannot
give you medical advice or an
individual diagnosis.
Keep this leaflet with your medicine.
You may want to read it again.
WHAT THIS MEDICINE IS
USED FOR
The name of your medicine is
Chemmart Indapamide. It contains
the active ingredient, indapamide
hemihydrate.
It is used either alone or with other
medicines to treat:
•
mild to moderate hypertension
(high blood pressure).
Ask your doctor if you have any
questions about why this medicine
has been prescribed for you. Your
doctor may have prescribed this
medicine for another reason.
This medicine is available only with
a doctor's prescription.
_HOW IT WORKS_
Indapamide, at a dose of 2.5 mg, is
thought to lower blood pressure by
relaxing some of the blood vessels in
the body. The blood vessels can then
carry the same volume of blood more
easily. It is not fully understood how
it exactly does this.
Indapamide can be used alone or in
combination with other medicines to
lower blood pressure.
Everyone has blood pressure. This
pressure helps get your blood all
around your body. Your blood
pressure may be different at different
times of the day, depend
                                
                                Прочитајте комплетан документ
                                
                            

Карактеристике производа

                                Product Information – Australia 
Chemmart Indapamide Tablets 
Page 1 
CHEMMART INDAPAMIDE 
 
 
NAME OF THE MEDICINE 
Indapamide hemihydrate. 
 
 
Chemical Name:  
Indapamide hemihydrate
is 4-chloro-N-(2-methyl-1-indolinyl)-3-sulfamoyl benzamide 
hemihydrate. 
 
Chemical Structure: 
 
Molecular Formula:    
C
16
H
16
CIN
3
O
3
S, ½ H
2
O 
 
Molecular weight: 
374.85. 
 
CAS Registry Number:  26807-65-8. 
 
DESCRIPTION 
 
Indapamide hemihydrate is a nonthiazide indole derivative
of chlorosulfonamide.  It is a white crystalline 
lipophilic powder, soluble in methanol, ethanol, acetic acid and
ethyl acetate, very slightly soluble in ether, 
chloroform and benzene and practically insoluble in water. Melting
point: approximately 185°C. 
 
 
PHARMACOLOGY 
PHARMACODYNAMICS 
Indapamide is an oral antihypertensive agent.  The
mechanism whereby indapamide exerts its 
antihypertensive action has not been completely elucidated; both vascular and renal actions have been 
implicated. 
 
At a dose of 2.5  mg the renal effects of indapamide are
minimal and the antihypertensive effect of 
indapamide has been attributed to a reduction in vascular reactivity to pressor amines.  The finding that 
indapamide retains its antihypertensive activity in
functionally anephric patients lends support to the 
hypothesis. 
 
The renal site of action of indapamide is the proximal segment of the
distal tubule.  Indapamide appears 
to have natriuretic properties (sodium and chloride being
excreted in equivalent amounts) with less effect 
on kaliuresis or uric acid excretion.  Only at doses greater than 2.5 mg/day is an appreciable increase in 
urinary volume observed  in humans.  No significant changes in
plasma sodium levels have been 
observed in clinical studies.  Significant hypokalaemia (plasma
potassium <  3.2 mmol/L  has been 
reported 
                                
                                Прочитајте комплетан документ
                                
                            

Обавештења о претрази у вези са овим производом

Погледајте историју докумената